CLINICAL_TRIALS
research
· 2012-06-04
Clinical Trial Update: Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma [Phase 2, Phase 3]
Summary
This entry reports a Phase 2/Phase 3 clinical trial comparing autologous and allogeneic bone marrow transplantation in multiple myeloma; current status is unkno…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Tehran University of Medical Sciences | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: UNKNOWN